Integrating multisector molecular characterization into personalized peptide vaccine design for patients with newly diagnosed glioblastoma

TM Johanns, EAR Garfinkle, KE Miller… - Clinical Cancer …, 2024 - AACR
Purpose: Outcomes for patients with glioblastoma (GBM) remain poor despite multimodality
treatment with surgery, radiation, and chemotherapy. There are few immunotherapy options …
被引用次数：1 相关文章

Integrating multisector molecular characterization into personalized peptide vaccine design for patients with newly diagnosed glioblastoma

TM Johanns, EAR Garfinkle, KE Miller… - … cancer research: an … - pubmed.ncbi.nlm.nih.gov
Purpose Glioblastoma (GBM) patient outcomes remain poor despite multimodality treatment
with surgery, radiation, and chemotherapy. There are few immunotherapy options due to the …

Integrating multisector molecular characterization into personalized peptide vaccine design for patients with newly diagnosed glioblastoma.

TM Johanns, EAR Garfinkle, KE Miller… - … Cancer Research: an …, 2024 - europepmc.org
Purpose Glioblastoma (GBM) patient outcomes remain poor despite multimodality treatment
with surgery, radiation, and chemotherapy. There are few immunotherapy options due to the …